Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $69.3 billion.

  • Universe Pharmaceuticals' Liabilities and Shareholders Equity rose 10198662493.07% to $69.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $69.4 billion, marking a year-over-year increase of 4284440.0%. This contributed to the annual value of $69.3 billion for FY2025, which is 10198662493.07% up from last year.
  • As of Q3 2025, Universe Pharmaceuticals' Liabilities and Shareholders Equity stood at $69.3 billion, which was up 10198662493.07% from $67953.4 recorded in Q3 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Liabilities and Shareholders Equity peaked at $69.3 billion during Q3 2025, and registered a low of $67953.4 during Q3 2024.
  • Over the past 5 years, Universe Pharmaceuticals' median Liabilities and Shareholders Equity value was $64.8 million (recorded in 2021), while the average stood at $8.7 billion.
  • Per our database at Business Quant, Universe Pharmaceuticals' Liabilities and Shareholders Equity soared by 24352182509.6% in 2021 and then crashed by 9983.71% in 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Liabilities and Shareholders Equity (Quarter) stood at $70.1 million in 2021, then dropped by 15.12% to $59.5 million in 2022, then decreased by 29.92% to $41.7 million in 2023, then tumbled by 99.84% to $67953.4 in 2024, then soared by 101986624.93% to $69.3 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $69.3 billion for Q3 2025, versus $67953.4 for Q3 2024 and $49.4 million for Q1 2024.